News and Announcements
Aeeris Quarterly Report June 2016: Solid Progress with Revenues and New Products, Robust Sales Pipeline
- Published August 02, 2016 12:59PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th July 2016, ASX Announcement
Financial Highlights
- Total cash receipts of $488,138
- Cash receipts received from customers of $477,629 compared with the previous quarter of $483,390
- Net decrease in cash held (cash burn) of $429,971 compared with $411,285 in the previous quarter
- Cash position at the end of quarter (30th June 2016) of $1.73 million (unaudited)
Business Highlights
- Solid quarter of progress with implementation of new customers and new products.
- Optimistic outlook for ongoing new sales activity, and expansion into new verticals and new markets.
- Strong internal team cohesion, especially in sales and business development.
- Ongoing optimisation of operations and review of expenses, cost reductions.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
